Thus, the question arises whether elevated gluconeogenic pathways in INT-offspring may be part of a compensatory mechanism to avoid hypoglycemia during a phase of increased insulin sensitivity at P21 and further research is needed to clarify the effects of ME on offspring hepatic gluconeogenesis. The gene discussed is INS; the disease is Hypoglycemia.